Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation

ISBN-13: 9781857282009 / Angielski / Miękka / 1995 / 324 str.

John Abraham

Opis

Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.

Spis treści

Bias in science and regulation; partial progress? the development of American and British drug regulation; Naprosyn - reconstructing data; Opren/Oraflex - the making of a drug disaster; Feldene - the closure of technical dispute; Zomax - the persistence of data; Suprol - anything goes?; conclusions and policy implications.

O autorze

Abraham, John, ; John Abraham University of Reading.,